Kyung Mook Choi Selected Research

P 569

8/2014

Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung Mook Choi Research Topics

Disease

40	Insulin Resistance 06/2022 - 06/2009
34	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2011
31	Obesity 01/2022 - 01/2008
27	Inflammation (Inflammations) 06/2022 - 03/2010
23	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021 - 11/2005
22	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 04/2007
21	Non-alcoholic Fatty Liver Disease 07/2021 - 07/2004
17	Atherosclerosis 10/2020 - 03/2006
8	Diabetes Mellitus 11/2022 - 01/2017
6	Hypertension (High Blood Pressure) 01/2022 - 08/2006
6	Abdominal Obesity 01/2019 - 11/2005
6	Body Weight (Weight, Body) 01/2019 - 10/2012
5	Dementia (Dementias) 11/2022 - 01/2019
5	Dyslipidemias (Dyslipidemia) 11/2022 - 01/2020
5	Stroke (Strokes) 01/2022 - 06/2019
5	Myocardial Infarction 01/2022 - 01/2018
5	Glucose Intolerance 09/2020 - 03/2010
5	Hypoglycemia (Reactive Hypoglycemia) 12/2017 - 10/2017
4	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 11/2019
4	Diabetes Complications 01/2021 - 12/2018
4	Diabetic Nephropathies (Diabetic Nephropathy) 12/2019 - 01/2005
3	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 10/2016
3	Metabolic Diseases (Metabolic Disease) 11/2021 - 01/2019
3	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021 - 01/2016
3	Sarcopenia 01/2020 - 08/2014
3	Weight Loss (Weight Reduction) 01/2020 - 03/2017
2	Frailty 01/2022 - 11/2021
2	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2020 - 01/2020
2	Fatty Liver 09/2020 - 01/2008
2	Fibrosis (Cirrhosis) 07/2020 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 07/2015
2	Heart Failure 01/2020 - 11/2019
2	Hypertriglyceridemia 01/2020 - 01/2018
2	Ischemic Stroke 11/2019 - 01/2018
2	Vitamin D Deficiency 11/2019 - 11/2015
2	Weight Gain 11/2017 - 10/2017

Drug/Important Bio-Agent (IBA)

32	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 08/2006
19	C-Reactive ProteinIBA 10/2018 - 03/2010
16	AdipokinesIBA 01/2020 - 06/2009
14	Triglycerides (Triacylglycerol)IBA 11/2021 - 11/2005
13	Insulin (Novolin)FDA Link 12/2021 - 06/2009
12	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2016
12	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2006
12	AdiponectinIBA 09/2018 - 03/2006
12	HDL CholesterolIBA 09/2018 - 11/2005
11	LipidsIBA 01/2022 - 09/2013
10	LDL CholesterolIBA 01/2022 - 01/2011
9	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 06/2017
8	Proteins (Proteins, Gene)FDA Link 09/2018 - 11/2012
7	CholesterolIBA 01/2022 - 08/2006
7	Indicators and Reagents (Reagents)IBA 12/2021 - 05/2014
6	Blood Glucose (Blood Sugar)IBA 11/2022 - 11/2011
6	Vitamin D FDA LinkGeneric 06/2022 - 01/2013
6	MyokinesIBA 01/2020 - 08/2014
5	oxidized low density lipoproteinIBA 01/2022 - 09/2013
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 11/2011
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 10/2012
4	TransferasesIBA 10/2020 - 01/2020
4	Pharmaceutical PreparationsIBA 01/2019 - 09/2010
4	alpha-2-HS-GlycoproteinIBA 09/2018 - 09/2013
4	EnzymesIBA 02/2018 - 01/2008
4	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2017 - 07/2014
4	Fatty Acids (Saturated Fatty Acids)IBA 09/2015 - 07/2004
3	PalmitatesIBA 09/2020 - 01/2013
3	JNK Mitogen-Activated Protein KinasesIBA 09/2020 - 09/2015
3	CytokinesIBA 12/2019 - 07/2015
3	Alanine Transaminase (SGPT)IBA 10/2018 - 11/2005
3	CreatinineIBA 10/2018 - 02/2017
3	HDL LipoproteinsIBA 09/2018 - 12/2005
3	Receptor for Advanced Glycation End ProductsIBA 01/2018 - 02/2012
3	Chemotactic FactorsIBA 01/2017 - 09/2015
3	hydroxide ionIBA 11/2015 - 01/2013
3	LC15-0444IBA 11/2015 - 07/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2015 - 01/2008
3	Fatty Acid-Binding ProteinsIBA 08/2014 - 06/2009
3	Selenoprotein PIBA 01/2014 - 01/2013
3	ProgranulinsIBA 01/2014 - 01/2013
2	IodineIBA 09/2022 - 10/2020
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2022 - 01/2022
2	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 10/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2021 - 11/2011
2	Sitagliptin Phosphate (Januvia)FDA Link 10/2020 - 01/2019
2	GinsenosidesIBA 09/2020 - 07/2020
2	AntioxidantsIBA 07/2020 - 11/2012
2	Hormones (Hormone)IBA 01/2020 - 10/2015
2	Atorvastatin (Lipitor)FDA Link 01/2020 - 09/2013
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 03/2010
2	Protein Kinases (Protein Kinase)IBA 01/2019 - 01/2014
2	Adenosine Monophosphate (AMP)IBA 01/2019 - 01/2014
2	ResistinIBA 09/2018 - 04/2011
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2018 - 06/2017
2	AlbuminsIBA 01/2018 - 01/2005
2	Transaminases (Aminotransferases)IBA 01/2017 - 11/2005
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 04/2015 - 07/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2015 - 01/2011

Therapy/Procedure

13	Therapeutics 09/2021 - 09/2013
3	Glycemic Control 01/2021 - 09/2013
3	Aftercare (After-Treatment) 12/2019 - 09/2010
2	Thyroidectomy 01/2022 - 10/2016
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 11/2019